Primary Site >> Liver Cancer

Gene >> FGF21

Journal: Mol Carcinog. 2006 Dec;45(12):934-42.
Title: Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.
Author: Huang, Xinqiang|Yu, Chundong|Jin, Chengliu|Yang, Chaofeng|Xie, Rui|Cao, Dongdong|Wang, Fen|McKeehan, Wallace L
PMID: 16929488
Journal: Mol Pharm. 2008 Jan-Feb;5(1):42-8.
Title: Mini-review: endocrine actions of fibroblast growth factor 19.
Author: Jones, Stacey
PMID: 18179175
Journal: J Biol Chem. 2010 Feb 19;285(8):5165-70.
Title: FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation.
Author: Wu, Xinle|Ge, Hongfei|Lemon, Bryan|Vonderfecht, Steven|Weiszmann, Jennifer|Hecht, Randy|Gupte, Jamila|Hager, Todd|Wang, Zhulun|Lindberg, Richard|Li, Yang
PMID: 20018895
Journal: Biol Pharm Bull. 2011;34(7):1120-1.
Title: Thiazolidinediones are potent inducers of fibroblast growth factor 21 expression in the liver.
Author: Oishi, Katsutaka|Tomita, Tatsunosuke
PMID: 21720023
Journal: Adv Exp Med Biol. 2012;728:195-213.
Title: Understanding the structure-function relationship between FGF19 and its mitogenic and metabolic activities.
Author: Wu, Xinle|Li, Yang
PMID: 22396171
Journal: Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):11592-9.
Title: Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.
Author: Cornu, Marion|Oppliger, Wolfgang|Albert, Verena|Robitaille, Aaron M|Trapani, Francesca|Quagliata, Luca|Fuhrer, Tobias|Sauer, Uwe|Terracciano, Luigi|Hall, Michael N
PMID: 25082895
Journal: Am J Cancer Res. 2015 Apr 15;5(5):1762-74. eCollection 2015.
Title: Loss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformation.
Author: Zhang, Quan|Li, Yan|Liang, Tingting|Lu, Xuemian|Liu, Xingkai|Zhang, Chi|Jiang, Xin|Martin, Robert C|Cheng, Mingliang|Cai, Lu
PMID: 26175944
Journal: PLoS One. 2015 Jun 29;10(6):e0131664.
Title: Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis.
Author: Yang, Mei|Xu, Dongping|Liu, Yuan|Guo, Xiaodong|Li, Wenshu|Guo, Chaonan|Zhang, Hongping|Gao, Yinjie|Mao, Yuanli|Zhao, Jingmin
PMID: 26121037
Journal: Oncotarget. 2015;6(12):9686-700.
Title: Forced expression of fibroblast growth factor 21 reverses the sustained impairment of liver regeneration in hPPARalpha(PAC) mice due to dysregulated bile acid synthesis.
Author: Liu, Hui-Xin|Hu, Ying|French, Samuel W|Gonzalez, Frank J|Wan, Yu-Jui Yvonne
PMID: 25991671
Journal: J Hepatol. 2015 Feb;62(2):421-9.
Title: Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice.
Author: Peyrou, Marion|Bourgoin, Lucie|Poher, Anne-Laure|Altirriba, Jordi|Maeder, Christine|Caillon, Aurelie|Fournier, Margot|Montet, Xavier|Rohner-Jeanrenaud, Francoise|Foti, Michelangelo
PMID: 25234947
Journal: Biochim Biophys Acta. 2016 Mar;1860(3):498-507.
Title: Mapping the response of human fibroblast growth factor 21 (FGF21) promoter to serum availability and lipoic acid in HepG2 hepatoma cells.
Author: Xia, Mengna|Erickson, Anjeza|Yi, Xiaohua|Moreau, Regis
PMID: 26691139
Journal: Front Cell Dev Biol. 2016 Apr 13;4:30.
Title: Roles of FGFs As Paracrine or Endocrine Signals in Liver Development, Health, and Disease.
Author: Itoh, Nobuyuki|Nakayama, Yoshiaki|Konishi, Morichika
PMID: 27148532
Journal: Am J Cancer Res. 2016 May 1;6(5):1011-25. eCollection 2016.
Title: Lack of fibroblast growth factor 21 accelerates metabolic liver injury characterized by steatohepatities in mice.
Author: Liu, Xingkai|Zhang, Ping|Martin, Robert C|Cui, Guozhen|Wang, Guangyi|Tan, Yi|Cai, Lu|Lv, Guoyue|Li, Yan
PMID: 27293995
Journal: Hum Mol Genet. 2017 May 15;26(10):1890-1899.
Title: Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy.
Author: Kim, Goo-Young|Kwon, Joon Hyun|Cho, Jun-Ho|Zhang, Lisa|Mansfield, Brian C|Chou, Janice Y
PMID: 28334808
Journal: Free Radic Res. 2017 Apr;51(4):368-374.
Title: Amelioration of late-onset hepatic steatosis in IDH2-deficient mice.
Author: Lee, Su Jeong|Cha, Hanvit|Kim, Hyunjin|Lee, Jin Hyup|Park, Jeen-Woo
PMID: 28415887
Journal: Oncotarget. 2017 Jun 13;8(24):38592-38601.
Title: Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma.
Author: Yoo, Changhoon|Kang, Jihoon|Kim, Deokhoon|Kim, Kyu-Pyo|Ryoo, Baek-Yeol|Hong, Seung-Mo|Hwang, Jung Jin|Jeong, Seong-Yun|Hwang, Shin|Kim, Ki-Hun|Lee, Young-Joo|Hoeflich, Klaus P|Schmidt-Kittler, Oleg|Miller, Stephen|Choi, Eun Kyung
PMID: 28445152
Journal: Sci Rep. 2017 Nov 28;7(1):16482.
Title: Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases.
Author: Wu, Liang|Pan, Qingchun|Wu, Guangyu|Qian, Lingling|Zhang, Jing|Zhang, Lei|Fang, Qichen|Zang, Guoqing|Wang, Yudong|Lau, George|Li, Huating|Jia, Weiping
PMID: 29184085
Journal: Mol Metab. 2018 Jul;13:56-66.
Title: Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet.
Author: Singhal, Garima|Kumar, Gaurav|Chan, Suzanne|Fisher, Ffolliott M|Ma, Yong|Vardeh, Hilde G|Nasser, Imad A|Flier, Jeffrey S|Maratos-Flier, Eleftheria
PMID: 29753678